Importantly, ERK activation also appeared to play a role in maintaining RIP1 expression through upregulation of Snail1 and downregulation of CYLD in melanoma cells acquired resistance to BRAF/MEK inhibitors (Fig. 6). Here, SNAI1 is linked to melanoma.